- Home
- The Bigger Picture: An Expert Assessment on the True Impact of ATTR-CM
The Bigger Picture: An Expert Assessment on the True Impact of ATTR-CM
- Amyloidosis
Available Credit:
- 1.00
Course Published On:
Course Expiry Date:
Overview
Radcliffe Medical Education bring together a globally-renowed faculty, first presented at ESC 2024, including Prof Julian Gillmore (University College London, London, UK) lead a distinguished faculty compromising of Dr Ahmad Masri (Oregon Health & Science University Medical Group, Portland, US), Dr Margot Davis (University of British Columbia, Vancouver, CA), and Dr Giuseppe Vergaro (Sant’Anna, Pisa, IT).
The faculty present recent epidemiological data on ATTR-CN incidence and trends. The session will teach how to identify patients who undergo detailed diagnosis and list the red flags indicating ATTR amyloidosis.
Terms & Conditions
Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.
The session, ‘The Bigger Picture: An Expert Assessment on the True Impact of ATTR-CM’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionalsand the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.
Support Statement
This activity is supported by an unrestricted educational grant from AstraZeneca. AstraZeneca has had no involvement in the selection of the speakers, the development of the activity, the agenda or the materials.
Instruction to Participants
There is no fee for taking part in this online learning activity.
Activities are designed to be completed within 90 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.
To complete the course and claim certification participants must:
- Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
- Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.
Target Audience
- Heart Failure Specialists
- Cardiac Amyloidosis Specialists
- Echocardiologists
Learning Objectives
- Recall the most recent epidemiological data on ATTR-CM incidence and diagnostic trends
- List red flags indicating the presence of ATTR amyloidosis
- Identify patients who should undergo detailed diagnosis work-up or referral
- List the advantages of emerging classes of agents being evaluated in ATTR-CM
Module |
Title |
Duration |
Speakers |
---|---|---|---|
Chapter 1 | Welcome and Introduction | 2m 49s | Julian Gillmore |
Chapter 2 | A Contemporary View of ATTR-CM Epidemiology | 11m 55s | Margot Davis |
Chapter 3 | Practical Screening: What's the Role of the Cardiologist? | 14m 35s | Giuseppe Vergaro |
Chapter 4 | Where Are We Now and What’s Next in Medical Management? | 17m 6s | Ahmad Masri |
Sesion 5 | Closing Remarks | 12m 10s | Julian Gillmore Ahmad Masri Margot Davis Giuseppe Vergaro |
Practical Screening: What's the Role of the Cardiologist?
Duration: 14m 35s
Speakers: Giuseppe Vergaro
Closing Remarks
Duration: 12m 10s
Speakers: Julian Gillmore Ahmad Masri Margot Davis Giuseppe Vergaro
Chair
Speaker
Speaker
The Bigger Picture: An Expert Assessment on the True Impact of ATTR-CM programme has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.